Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
8.30
+0.06 (0.73%)
Dec 11, 2025, 4:00 PM EST - Market closed
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $132.72 million as of December 12, 2025. Its market cap has increased by 47.87% in one year.
Market Cap
132.72M
Enterprise Value
147.36M
1-Year Change
47.87%
Ranking
Category
Stock Price
$8.30
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $132.72M, a decrease of -69.60%. That is a compound annual growth rate of -14.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 132.72M | 109.35% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | 297.71M | -27.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |